Effect of prednisolone and cetirizine on D. farinae and histamine-induced wheal and flare response in healthy dogs;Auswirkungen von Cetirizin und Prednisolon auf die Resultate des Intra-kutantests bei gesunden Hunden

Tierarztliche Praxis Ausgabe K: Kleintiere - Heimtiere

Volumn 39, Issue 1, 2011, Pages 25-30

  Temizel, E M ^a   Cihan, H ^a   Akhtardanesh, B ^b   Aytug, N ^a  

^a ULUDAG UNIVERSITY   (Turkey)

^b SHAHID BAHONAR UNIVERSITY OF KERMAN   (Iran)

Author keywords

Antihistamines; Atopia; Canine; Intradermal testing

Indexed keywords

CANIS FAMILIARIS;

ANTIALLERGIC AGENT; ANTIINFLAMMATORY AGENT; CETIRIZINE; HISTAMINE; PREDNISOLONE;

ANIMAL; ANIMAL DISEASE; ARTICLE; ATOPIC DERMATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHAGOIDES FARINAE; DOG; DOG DISEASE; FEMALE; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; MALE; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS; CETIRIZINE; DERMATITIS, ATOPIC; DERMATOPHAGOIDES FARINAE; DOG DISEASES; DOGS; FEMALE; HISTAMINE; INJECTIONS, INTRADERMAL; MALE; PREDNISOLONE;

EID: 84866603611     PISSN: 14341239     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1622566     Document Type: Article

References (33)

1. Anveden I, Lindberg M, Andersen KE, Bruze M, Isaksson M, Liden C, et al. Oral prednisone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickel. Contact Dermatitis 2004; 50: 298-303. (Pubitemid 38869904)
2. Barata TL, Jacobson M, Walker S, Njuki F, Ying S, Randev P, et al. Effect of cetirizine and prednisolone on cellular infiltration and cytokine mRNA expression during allergen-induced late cutaneous responses. Clin Exp Allergy 1996; 26: 68-78. (Pubitemid 26036137)
3. Barbet JL, Halliwell REW. Duration of inhibition of immediate skin test reactivity by hydroxyzine hydrochloride in dogs. J Am Vet Med Assoc 1989; 11: 1565-1569. (Pubitemid 19142411)
4. Barnes PJ. Corticosteroids, IgE, and atopy. J Clin Invest 2001; 107: 265-266.
5. Bizikova P, Papich MG, Olivry T. Hydroxyzine and cetirizine pharmacokinetics and pharmacodynamics after oral and intravenous administration of hydroxyzine to healthy dogs. Vet Dermatol 2008; 19: 348-357.
6. Carlotti DN, Costargent F. Analysis positive skin tests in 449 dogs with allergic dermatitis. Eur J Allergy Clin Immunol 1994; 4: 42-59.
7. Charlesworth EN, Kagey SA, Norman PS, Lichtenstein LM. Effect of cetiri - zine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. J Allergy Clin Immunol 1989; 83: 905-912. (Pubitemid 19147182)
8. Cook CP, Scott DW, Miller WH, Kirker JE, Cobb SM. Treatment of canine atopic dermatitis with cetirizine, a second generation antihistamine: A single-blinded, placebo-controlled study. Can Vet J 2004; 45: 414-417. (Pubitemid 38765481)
9. Coulie PJ, Ghys L, Rihoux JP. Inhibitory effects of orally or sublingually administered cetirizine on histamine-induced wheals and flares and their correlation with cetirizine plasma concentrations. J Int Med Res 1991; 19: 174-179.
10. De Boer DJ, Griffin CE. The ACVD task force on canine atopic dermatitis (XXI): Antihistamine pharmacotherapy. Vet Immunol Immunopathol 2001; 81: 323-329. (Pubitemid 32842887)
11. De Vos C, Maleux MR, Baltes E, Gobert J. Inhibition of histamine and allergen skin wheal by cetirizine in four animal species. Ann Allergy 1987; 59: 278-282. (Pubitemid 17151171)
12. Demoly P, Michel FB, Bousquet J. In vivo methods for study of allergy: skin tests, techniques and interpretation In: Allergy Principles and Practice, 5th ed. Middleton E, Reed CE, Ellis EF et al., eds. St. Louis: Mosby 1998; 430-439.
13. Des Roches A, Paradis L, Bougeard YH, Godard P, Bousquet J, Chanez P. Long-term oral corticosteroid therapy does not alter the results of immediate- type allergy skin prick tests. J Allergy Clin Immunol 1996; 98: 522-527. (Pubitemid 26377917)
14. Devalia JL, De Vos C, Hanotte F, Baltes E. A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine- induced cutaneous responses in healthy adult volunteers. Allergy 2001; 56: 50-57. (Pubitemid 32099072)
15. Fadel R, David B, Herpin RN, Borgnon A, Rassemont R, Rihoux JP. In vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by plateletactivating factor PAF-acether in man. J Allergy Clin Immunol 1990; 86: 314-320. (Pubitemid 20305633)
16. Frossard N, Melac M, Benabdesselam O, Pauli G. Consistency of the efficacy of cetirizine and ebastine on skin reactivity. Ann Allergy Asthma Immunol 1998; 80: 61-65. (Pubitemid 28086758)
17. Ginel PJ, Garrido C, Lucena R. Effects of otic betamethasone on intradermal testing in normal dogs. Vet Dermatol 2007; 18: 205-210. (Pubitemid 47140991)
18. Herman S, Vender RB. Antihistamines in the treatment of atopic dermatitis. J Cutan Med Surg 2003; 7 (6): 467-473. (Pubitemid 38233357)
19. Hillier A, De Boer DJ. The ACVD task force on canine atopic dermatitis XVII: intradermal testing. Vet Immunol Immunopathol 2001; 20: 289-304. (Pubitemid 32842884)
20. Juhlin L, De Vos C, Rihoux J. Inhibiting effect of cetirizine on histamine-induced and 48/80-inducedwheals and flares, experimental dermographism, and cold-inducedurticaria. J Allergy Clin Immunol 1987; 80: 599-602. (Pubitemid 17164197)
21. Juhlin LA. Comparison of the pharmacodynamics of H1-receptor antagonists as assessed by the induced wheal-and-flare model. Allergy 1995; 50: 24-30.
22. Michel L, De Vos C, Rihoux JP, Burtin C, Benveniste J, Dubertret L. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAFacether release and eosinophil recruitment in human skin. J Allergy Clin Immunol 1988; 82: 101-109.
23. Pipkorn U, Hammarlund A, Enerback L. Prolonged treatment with topical glucocorticoids results in an inhibition of the allergen-induced wheal-andflare response and a reduction in skin mast cell numbers and histamine content. Clin Exp Allergy 1989; 19: 19-25. (Pubitemid 19080281)
24. Pucheu-Haston CM, Shuster D, Olivry T, Brianceau P, Lockwood P, McClanahan, et al. A canine model of cutaneous late-phase reactions: predniso - lone inhibition of cellular and cytokine responses. Immunology 2006; 117: 177-187.
25. Rees C. New drugs in veterinary dermatology. Vet Clin North Am Small Anim Pract 1999; 29: 1449-1460. (Pubitemid 29513994)
26. Rivierre C, Dunston SM, Olivry T. Effects of a 1 per cent hydrocortisone conditioner on the prevention of immediate and late-phase reactions in canine skin. Vet Rec 2000; 147: 739-742. (Pubitemid 32047132)
27. Scott DW, Miller WH, Griffin CE. Atopic dermatitis In: Small Animal Dermatology, 5th ed. Philadelphia, PA: Saunders 2001; 574-601.
28. Simons FE. Evolution of H1-receptor antagonist treatment. Ann Allergy 1993; 71: 282-287.
29. Snyder SH, Snowman AM. Receptor effects of cetirizine AM. Ann Allergy 1987; 59, 4-8.
30. Spencer C, Faulds D, Peters D. Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders. Drugs 1993; 46: 1055-1080. (Pubitemid 24016645)
31. Sture GH, Halliwell RE, Thoday KL, Van den Broek AH, Henfrey JI, Lloyd DH, et al. Canine atopic disease: the prevalence of positive intradermal skin tests at two sites in the north and south of Great Britain. Vet Immunol Immunopathol 1995; 44: 293-308.
32. Takahashi H, Ishida-Yamamoto A, Iizuka H. Effects of bepotastine, cetiri - zine, fexofenadine, and olopatadine on histamine-induced wheal-and flareresponse, sedation, and psychomotor performance. Clin Exp Dermatol 2004; 29: 526-532. (Pubitemid 39278201)
33. Thomas RC, Logas D, Radosta L. Effects of a 1% hydrocortisone conditioner on hematological and biochemical parameters, adrenal function testing and cutaneous reactivity to histamine in normal and pruritic dogs. Vet Dermatol 1999; 10: 109-116. (Pubitemid 129632836)